Trade, Inc.
ENID
Start free

Diastika Biotekindo Tbk.

CHEK · Kesehatan · Jasa & Peralatan Kesehatan

103

-42.78% 1-year change

Last completed session, Oct 16, 2026

Daily closes over the past year, to Oct 16, 2026

What makes up the 32

  • Value

    36Against 788 other IDX companies

    Expensive against comparable stocks.

    P/E
    34.6×
    43%Cheaper than 43% of other IDX companies
    P/B
    2.09×
    29%Cheaper than 29% of other IDX companies
    Dividend yield
    —
    —Not ranked

  • Quality

    57Against 788 other IDX companies

    About as profitable as comparable stocks.

    Return on equity
    6.1%
    53%Higher than 53% of other IDX companies
    Return on assets
    4.9%
    64%Higher than 64% of other IDX companies
    Net margin
    6%
    55%Higher than 55% of other IDX companies

  • Growth

    36Against 788 other IDX companies

    Growing slower than most comparable stocks.

    Profit, last 4 quarters
    -44%
    21%Higher than 21% of other IDX companies
    Profit, 3-year yearly
    +2.5%
    46%Higher than 46% of other IDX companies
    Profit, latest quarter vs a year ago
    -12.2%
    39%Higher than 39% of other IDX companies
    Revenue, latest quarter vs a year ago
    +5.2%
    38%Higher than 38% of other IDX companies

  • Momentum

    22Against 836 traded stocks

    Has lagged most stocks over the past year.

    1-year price change
    -42.1%
    22%Better than 22% of traded stocks

  • Liquidity

    17Against 836 traded stocks

    Thinly traded compared with most IDX stocks.

    Value traded per day, 30 days
    IDR 94M
    17%Higher than 17% of traded stocks

  • Retail penalty

    −2Retail brokers XL, XC, RO, YP, past 20 sessions

    Retail is underwater here, deeper than 40% of the other stocks where it is, so 2 points come off the rating.

    Retail average buy
    120
    Close vs that average
    -13.8%
    Retail net bought
    -9.2K lots

Similar stocks

Rated most like CHEK across the five pillars. Change is over the past year.